- Business
- China National Uranium Co., Ltd. (001280.SZ) engages in the procurement, mining, smelting, sales, and trading of natural uranium resources, as well as the comprehensive utilization and product sales of radioactive co-associated mineral resources including monazite, uranium-molybdenum, tantalum-niobium, uranium-iron, and others; its core products comprise rare earth chlorides, ammonium tetramolybdate, tantalum pentoxide, niobium pentoxide, and related rare earth oxides utilized in nuclear power generation, national defense, rare earth smelting, and rare metal sectors. The company also invests in and manages overseas uranium resource projects encompassing exploration, surveying, design, engineering construction, import/export operations, technology development, technical services, and consulting, with advanced capabilities in CO₂+O₂ in-situ leaching technology for complex sandstone-type uranium deposits, multi-layer ore body mining, high-grade ore leaching, and integrated recovery of uranium, thorium, rare earths, molybdenum, and other rare metals. Founded in 1989 and headquartered in Building 26, 1st Floor, Beijing, China, it operates primarily in the metals and mining sub-industry within the capital goods sector, serving nuclear energy, defense, and industrial customers through domestic projects in regions such as Ordos in Inner Mongolia and international partnerships.
A subsidiary of China National Nuclear Corporation (CNNC), the company maintains key strategic alliances, including long-term uranium supply contracts with NAC Kazatomprom JSC since 2019 (valued at RMB 6.02 billion in 2024 procurement), Cameco Corporation (RMB 1.32 billion in 2024), Orano SA since 2016, WMC Energy B.V. since 2020, and others like CNNC Group and CGN Group, alongside involvement in global projects such as Rossing Uranium. In recent major developments, it listed on the Shenzhen Stock Exchange main board on December 3, 2025, under ticker 001280 as the first natural uranium stock in the A-share market, raising funds for domestic natural uranium expansion and radioactive resource utilization to bolster production capacity and national energy security. Additionally, its National Uranium No.1 Demonstration Project in Ordos, Inner Mongolia—the largest domestic uranium initiative—produced its first barrel of natural uranium in July 2025, just one year after construction began, pioneering rapid in-situ leaching advancements now targeted for northern Chinese basins and global export. Converted to a joint stock company on March 30, 2023, ahead of its IPO prospectus filed in August 2025, these milestones enhance its role in China's nuclear fuel supply chain and "three-step" nuclear strategy.